About the Authors
- Tobias Meischl
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft
Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria
- Susanne Rasoul-Rockenschaub
-
Roles Writing – review & editing
Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria
- Georg Györi
-
Roles Writing – review & editing
Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria
- Wolfgang Sieghart
-
Roles Conceptualization, Methodology, Supervision, Writing – review & editing
Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria
- Thomas Reiberger
-
Roles Writing – review & editing
Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria
- Michael Trauner
-
Roles Supervision, Writing – review & editing
Affiliation Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
- Thomas Soliman
-
Roles Writing – review & editing
Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria
- Gabriela Berlakovich
-
Roles Writing – review & editing
Affiliation Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria
- Matthias Pinter
-
Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing
* E-mail: matthias.pinter@meduniwien.ac.at
Affiliations Division of Gastroenterology und Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria
Competing Interests
We have read the journal's policy and the authors of this manuscript have the following competing interests: T.M. declares no competing interests. S.R.-R. declares no competing interests. G.G. declares no competing interests. W.S. received speaker and consulting fees and research grants from Bayer Schering Pharma; he also served as consultant for Eisai, Lilly, and BMS. T.R. has received grant support from Abbvie, Boehringer-Ingelheim, Gilead, MSD, Philips Healthcare, Gore; speaking honoraria from Gilead, Gore, Intercept, Roche, MSD; consulting/advisory board fee from Abbvie, Boehringer-Ingelheim, Gilead, MSD; and travel support from Boehringer-Ingelheim, Gilead and Roche. M.T. served as speaker for BMS, Falk, Gilead, and MSD; advisory boards for Albireo, Falk, Genfit, Gilead, Intercept, MSD, Novartis, Phenex, and Regulus. He further received travel grants from Abbvie, Falk, Gilead, and Intercept, and unrestricted research grants from Albireo, Cymabay, Falk, Gilead, Intercept, MSD, and Takeda. He is also co-inventor of a patent on the medical use of norUDCA. T.S. declares no competing interests. G.B. has received grant support from Sandoz, Chiesi, MSD, Shire; speaking honoraria from Neovii, Chiesi, Astellas; consulting/advisory board fee from Astellas, Neovii, Chiesi, Sanofi; and travel support from Astellas, Chiesi, Neovii, Biotest. M.P. served as consultant for Bayer, BMS, Eisai, and Ipsen, and received travel support from Bayer and speaking fees from Bayer and BMS. He is also an investigator for Bayer, BMS and Lilly. This does not alter our adherence to PLOS ONE policies on sharing data and materials.